CONMED Corporation (CNMD)
 NYSE: CNMD · Real-Time Price · USD
 44.49
 -2.22 (-4.75%)
  Oct 30, 2025, 4:00 PM EDT - Market closed
CONMED Revenue
CONMED had revenue of $342.35M in the quarter ending June 30, 2025, with 3.09% growth. This brings the company's revenue in the last twelve months to $1.33B, up 3.94% year-over-year. In the year 2024, CONMED had annual revenue of $1.31B with 5.00% growth.
Revenue (ttm) 
 $1.33B
Revenue Growth 
 +3.94%
P/S Ratio 
 1.04
Revenue / Employee 
 $340,063
Employees 
 3,900
Market Cap 
1.38B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth | 
|---|---|---|---|
| Dec 31, 2024 | 1.31B | 62.27M | 5.00% | 
| Dec 31, 2023 | 1.24B | 199.27M | 19.06% | 
| Dec 31, 2022 | 1.05B | 34.84M | 3.45% | 
| Dec 31, 2021 | 1.01B | 148.18M | 17.18% | 
| Dec 31, 2020 | 862.46M | -92.64M | -9.70% | 
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue | 
|---|---|
| UnitedHealth Group | 435.16B | 
| Johnson & Johnson | 92.15B | 
| Merck & Co. | 64.24B | 
| Eli Lilly and Company | 59.42B | 
| AbbVie | 58.33B | 
| AstraZeneca | 56.50B | 
| Novartis AG | 56.37B | 
| Novo Nordisk | 49.11B | 
CNMD News
- 4 weeks ago - CONMED Corporation to Announce Third Quarter 2025 Financial Results on November 5, 2025 - Business Wire
- 7 weeks ago - CONMED Corporation Adds Kim Kelderman to its Board of Directors - Business Wire
- 2 months ago - CONMED Corporation Announces Quarterly Cash Dividend - Business Wire
- 3 months ago - CONMED Corporation (CNMD) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - CONMED Corporation Announces Second Quarter 2025 Financial Results - Business Wire
- 4 months ago - Martha Aronson to Step Down from CONMED Board of Directors Following Appointment as President and Chief Executive Officer of Merit Medical Systems, Inc. - Business Wire
- 4 months ago - CONMED Corporation to Announce Second Quarter 2025 Financial Results on July 30, 2025 - Business Wire
- 5 months ago - CONMED Corporation Appoints LaVerne Council as Chair of the Board of Directors - Business Wire